The ultrasound-guided multiple-injection costotransverse block for mastectomy and primary reconstructive surgery. A double blind, randomised, placebo controlled trial.

Associate Professor, Consultant Jens Børglum0 个研究点目标入组 36 人开始时间: 2019年3月14日最近更新: 2022年3月2日

适应症

试验速览

暂无简介。

•Scheduled for elective unilateral mastectomy and primary reconstructive surgery (UMPR) with subpectoral implant due to breast cancer
•Age above/equal to 18 years at the date of inclusion
•Have received thorough information, orally and in written, and signed the Informed Consent” form on participation in the study.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 30
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 6

•Scheduled for elective UMPR surgery due to breast cancer combined with simultaneous contralateral major breast surgery (mastectomy, mastopexy and subpectoral breast reconstruction). Minor contralateral surgery (e.g. lipofilling) are accepted.
•Scheduled free flap reconstructive surgery
•Inability to cooperate
•Inability to speak, read and understand Danish
•Allergy to local anaesthetics or opioids
•Daily intake of opioids, according to the investigators decision
•Illegal drug and/or substance abuse, according to the investigators decision
•Local infection at the site of injection or systemic infection
•Difficult sonoanatomical visualisation of the target area necessary for the block execution
•Substantial co-morbidity, ASA>3
•Severe hypovolemia
•Pregnant or breastfeeding

发起方

Associate Professor, Consultant Jens Børglum